Notable Labs stock analysis
Want to see NTBLQ full AI Analyst Report?
Notable Labs (NTBLQ) Stock Price & Analysis
NTBLQ Stock Chart & Stats
- Day’s Range
- $0.02 - $0.02
- 52-Week Range
- $0.02 - $0.02
- Previous Close
- $0.02
- Volume
- N/A
- Average Volume (3M)
- 71.68K
- Market Cap
- $10
- Enterprise Value
- $9.71M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $2.56M
- Price to Earnings (P/E)
- ―
- Beta
- -57.69
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Partnership Revenue Model
The company's revenue model, based on strategic partnerships, provides a scalable path to growth by leveraging external expertise and resources.
Biotechnology Industry Growth
The biotechnology sector's growth potential offers a favorable backdrop for Notable Labs to expand its market presence and capitalize on industry trends.
Manageable Debt Levels
Low leverage provides financial flexibility and reduces risk, allowing the company to focus on strategic investments and operational improvements.
Bears Say
Ongoing Losses
Persistent losses hinder the company's ability to reinvest in growth opportunities and may necessitate additional financing, impacting long-term sustainability.
Negative Cash Flows
Negative cash flows indicate operational inefficiencies and reliance on external funding, which could constrain future growth and financial stability.
Profitability Challenges
Ongoing profitability issues limit the company's ability to generate shareholder value and reinvest in R&D, crucial for long-term competitiveness.
NTBLQ FAQ
What was Notable Labs’s price range in the past 12 months?
What is Notable Labs’s market cap?
When is Notable Labs’s upcoming earnings report date?
How were Notable Labs’s earnings last quarter?
Is Notable Labs overvalued?
Does Notable Labs pay dividends?
What is Notable Labs’s EPS estimate?
How many shares outstanding does Notable Labs have?
What happened to Notable Labs’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Notable Labs?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Notable Labs
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kaile A. Zagger
- Employees
- 16
- Website
- www.vblrx.com
- Address
- 8 HaSatat Street, Modi'in, 7178106, IL
Notable Labs (NTBLQ) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 5 |
| Technical Analysis | 2 | 0 | 3 |
| Moving Averages | 2 | 2 | 2 |

